A study to compare vaginal and sublingual routes of misoprostol following mifepristone for second trimester(13-20 weeks period of gestation) abortions
- Conditions
- Health Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complications
- Registration Number
- CTRI/2020/04/024818
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Females in above mentioned age group with singleton viable intrauterine pregnancy
2.Gestational age 13-20weeks
3.Women fulfilling the pre-requisites of Indian MTP Act, 1972
1.Prior 2 or more uterine surgeries
2.Having either taken MTP pill from outside or self prescribed or with inevitable or incomplete abortion
3.Moderate or severe anaemia(Hb <8gm/dl)
4.Heart disease, uncontrolled HTN(140/90mmHg), bronchial asthma, coagulation disorder and any other medical illness
5.Known hypersenstivity to mifepristone or misoprostol
6.Hemodynamically unstable at the time of presentation
7.Contra-indications to the use of mifepristone or misoprostol like ectopic pregnancy, inherited porphyria, chronic adrenal failure , on immunosuppressants
8.Presence of vaginal discharge suggestive of vaginitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method